Greetings from MyCancerHaven!
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Pesticides as big a cancer risk as smoking
Podcast: Putting Patients First
US Cancer Survivor Population Projected to Reach 26 Million by 2040
Issues With Prior Authorization Result In Patients Forgoing Care
"Keep your face to the sunshine and you cannot see a shadow."
Next Steps for Pirtobrutinib Therapy in Chronic Lymphocytic Leukemia
Blinatumomab Plus Consolidation Chemotherapy Extends OS in MRD– B-Cell Precursor ALL
Impact of FDA Approval of Pirtobrutinib in R/R CLL Treatment
Flexible Monitoring for CAR T-Cell Therapy May Improve Treatment Access
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Pesticides as big a cancer risk as smoking
Podcast: Putting Patients First
US Cancer Survivor Population Projected to Reach 26 Million by 2040
Issues With Prior Authorization Result In Patients Forgoing Care
"Keep your face to the sunshine and you cannot see a shadow."
Next Steps for Pirtobrutinib Therapy in Chronic Lymphocytic Leukemia
Blinatumomab Plus Consolidation Chemotherapy Extends OS in MRD– B-Cell Precursor ALL
Impact of FDA Approval of Pirtobrutinib in R/R CLL Treatment
Flexible Monitoring for CAR T-Cell Therapy May Improve Treatment Access
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
